Neurocrine Biosciences, Inc.
NBIX
$155.80
$5.213.46%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/29/2025
-
MarketBeat
5/12/2026
-
SeekingAlpha
5/12/2026
-
Seeking Alpha: Transcripts
5/11/2026
-
Simply Wall St
5/11/2026
-
MarketBeat
5/11/2026
-
The Cerbat Gem
5/10/2026
-
MarketBeat
5/9/2026
-
The Cerbat Gem
5/8/2026
-
MarketBeat
5/8/2026
-
Zacks Investment Research
5/8/2026
-
Zacks Investment Research
Neurocrine Biosciences, Inc. Just Recorded A 61% EPS Beat: Here's What Analysts Are Forecasting Next
5/8/2026
-
Simply Wall St
5/7/2026
-
Zacks Investment Research
5/7/2026
-
Zacks Investment Research
5/7/2026
-
MarketBeat
5/7/2026
-
The Cerbat Gem
5/7/2026
-
Tickeron - Stocks
5/7/2026
-
MarketBeat
5/7/2026
-
Simply Wall St
5/6/2026
-
SeekingAlpha
5/6/2026
-
Seeking Alpha - Healthcare
5/6/2026
-
Seeking Alpha - Long Ideas
5/6/2026
-
The Cerbat Gem
5/6/2026
-
MarketBeat
5/6/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 5, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Jul 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 617 7600
Address
6027 Edgewood Bend Court
San Diego, CA 92130
San Diego, CA 92130
Country
Year Founded
Business Description
Sector
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally...
more